Effect of Glomerulopathy Recurrence in the Outcome and Graft Survival of Kidney Transplanted Patients

• Published in: Transplantation proceedings Vol. 52; no. 5; pp. 1272 - 1278
• Main Authors: Figueiredo Júnior, Humberto E., Nascimento, Evaldo, Lasmar, Marcus F., Siqueira, Raquel G., Sousa, Rayane N., Fabreti-Oliveira, Raquel A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-06-2020
• ISSN: 0041-1345; 1873-2623
• DOI: 10.1016/j.transproceed.2020.02.030

Recurrent glomerulopathy (GP) after kidney transplantation is a complication of kidney transplantation that could negatively affect kidney function and graft survival. This study aimed to evaluate the outcome, graft survival, and GP recurrence and its predictive factors in kidney-transplanted patients.
Patients were divided into 2 groups: G1 (with GP; n = 95) and G2 (with other causes of end-stage renal disease; n = 373). Graft survival analyses were performed using the Kaplan-Meier for living donor (LD) and deceased donor (DD). Cox proportional hazards regression were used to investigate the predictors for graft loss and for GP recurrence.
Disease recurrence was observed in 9 patients who received a kidney from an LD, of which 4 lost their grafts. In patients who received a kidney from a DD, recurrence was also observed in 9 patients, of which 3 lost their grafts. No statistically significant differences in graft survival between G1 and G2 in relation to LD and DD were noted (P = .299 and .434, respectively). However, differences in graft survival were found when GP subtypes and GP recurrence were analyzed. The predictors of graft loss were delayed graft function (hazard ratio [HR] = 2.226, P = .002), rejection episodes (HR = 1.904, P = .017), and recurrence or transplant GP (HR = 3.243, P = .006). The predictors of disease recurrence or transplant GP were age (HR = 0.945, P = .028) and cold ischemia time (HR = 1.117, P = .003).
Kidney transplantation could be a reasonable treatment for GP with end-stage renal disease. Despite the disease recurrence, which is a significant cause of graft loss in transplant recipients, graft survival remains satisfactory.